96 A new study has found that using mesh to rebuild the abdominal wall after tumour removal is a safe and effective method, offering long-term benefits with minimal complications. The findings bring hope to patients suffering from desmoid tumours, a rare and often aggressive condition that affects soft tissue. The findings were published in the journal Hernia. Desmoid tumours do not spread to other parts of the body, but they grow aggressively where they develop. The abdominal wall is one of the most common areas affected. Surgery is often the only option, yet removing these tumours typically leaves large and complex defects in the abdominal wall. Reconstructing these defects is notoriously difficult, especially when the tumour is near bones, organs, or major blood vessels. The study, conducted in Beijing, followed 16 patients who had large sections of abdominal wall removed due to desmoid tumours. Each patient then underwent immediate reconstruction using mesh to reinforce the weakened area. Over an average follow-up period of nearly seven years, most patients recovered well with few complications and only one case of tumour recurrence. Biologic mesh, made from processed human or animal tissue, was the preferred choice in most of the surgeries. It is particularly effective in cases involving previous infections or internal organ removal. The study highlighted its advantages in tolerating contamination and reducing the risk of adhesions or future surgery complications. However, the cost of biologic mesh remains high and may not be accessible to all patients. Importantly, none of the patients developed hernias or abdominal bulging during the follow-up period, a common concern in abdominal wall reconstruction. Complications were rare and mild. Only one patient developed a fluid build-up known as a seroma, which resolved on its own, and two patients reported unusual sensations near the surgical area but did not require further treatment. The research also revealed a significant link between desmoid tumours and previous surgical procedures, particularly caesarean sections. Most patients in the study were women, and 14 out of 16 had undergone abdominal surgery in the past. This pattern suggests that surgical trauma, combined with hormonal changes during pregnancy, may increase the risk of tumour development. While the findings are encouraging, the study authors noted that mesh-reinforced reconstruction may not be suitable in every case. In some patients, particularly where tumours invade bone or vital structures, it may be impossible to fully remove the tumour or reconstruct the area completely. Despite this, the surgical technique used in this study has shown promise in restoring abdominal strength and preventing further complications. The study offers valuable insights into the long-term effectiveness of mesh-based reconstruction in complex abdominal surgeries. It also reinforces the need for personalised treatment strategies, particularly in patients with prior surgical histories or complex tumour locations.